Overview
Prospectively study the correlation between Leucine-rich α2-glycoprotein (LRG) and clinical/endoscopic/histological disease activity in patients with inflammatory bowel disease (IBD) in Europe.
Eligibility
Inclusion Criteria:
- ≥18 years
- Patient with confirmed diagnosis of IBD
- Patient with planned endoscopy (ileocolonoscopy for Crohn's disease (CD)/ulcerative colitis (UC) or sigmoidoscopy for UC) for the assessment of endoscopic disease activity according to routine practice
- willing to provide informed consent
Exclusion Criteria:
- Patient with IBD unspecified
- Patient with ileo- or colostomy
- Patient with total colectomy
- Women that are pregnant


